Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Specialties, Oncology
Cover of the book Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319689296
Publisher: Springer International Publishing Publication: November 25, 2017
Imprint: Springer Language: English
Author:
ISBN: 9783319689296
Publisher: Springer International Publishing
Publication: November 25, 2017
Imprint: Springer
Language: English

This volume reviews the current state of research on immune checkpoints and offers novel concepts. It discusses the two most important immune checkpoints: T lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death-1 (PD-1). It shows that antagonistic antibodies against these two molecules are highly effective in the treatment of various cancers and that PD-1 and CTLA-4 have been linked to the suppression of T-cell receptor signaling and co-stimulatory molecules. Further, the volume examines other agents, a number of cells, receptors and signaling molecules, that are also involved in the regulation of T-cell activation and extends the concept of immune checkpoints to “molecules and cells that negatively regulate T-cell activation”. Playing essential roles in immune homeostasis, they could offer new targets for cancer immunotherapy, and for the therapy of autoimmune diseases.

Written by internationally respected scientists, this book will appeal to basic scientists, clinicians, drug development researchers, and advanced students alike.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This volume reviews the current state of research on immune checkpoints and offers novel concepts. It discusses the two most important immune checkpoints: T lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death-1 (PD-1). It shows that antagonistic antibodies against these two molecules are highly effective in the treatment of various cancers and that PD-1 and CTLA-4 have been linked to the suppression of T-cell receptor signaling and co-stimulatory molecules. Further, the volume examines other agents, a number of cells, receptors and signaling molecules, that are also involved in the regulation of T-cell activation and extends the concept of immune checkpoints to “molecules and cells that negatively regulate T-cell activation”. Playing essential roles in immune homeostasis, they could offer new targets for cancer immunotherapy, and for the therapy of autoimmune diseases.

Written by internationally respected scientists, this book will appeal to basic scientists, clinicians, drug development researchers, and advanced students alike.

More books from Springer International Publishing

Cover of the book Perspectives in Environmental Toxicology by
Cover of the book Compatibility of Transactional Resolutions of Antitrust Proceedings with Due Process and Fundamental Rights & Online Exhaustion of IP Rights by
Cover of the book International Conference on Security and Privacy in Communication Networks by
Cover of the book Reconstructing the War Injured Patient by
Cover of the book Memetic Computation by
Cover of the book Plasma and Thermal Spraying by
Cover of the book Graph Transformation, Specifications, and Nets by
Cover of the book Motion Control of Underactuated Mechanical Systems by
Cover of the book An Intraoperative Beta−Probe for Cancer Surgery by
Cover of the book KI 2018: Advances in Artificial Intelligence by
Cover of the book On-Surface Synthesis II by
Cover of the book Database Systems for Advanced Applications by
Cover of the book Innovations and Interdisciplinary Solutions for Underserved Areas by
Cover of the book Progress in Ultrafast Intense Laser Science XIV by
Cover of the book Landscapes and Landforms of Belgium and Luxembourg by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy